MODY1 Clinical Trial
Official title:
Investigating Glucagon Secretion in HNF1-alpha and HNF4-alpha MODY
The aim of this study is to determine whether fasting and post-prandial glucagon secretion is suppressed by gliclazide in patients with HNF1-/4-alpha MODY. Participants will undergo an oral glucose tolerance test (OGTT) before and after omitting their gliclazide medication for 3 days.
n/a